共 16 条
Pharmacokinetics in pregnancy
被引:136
作者:
Dawes, M
[1
]
Chowienczyk, PJ
[1
]
机构:
[1] St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England
来源:
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
|
2001年
/
15卷
/
06期
关键词:
pharmacokinetics;
half-life;
clearance;
dose;
bioavailability;
distribution;
D O I:
10.1053/beog.2001.0231
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distributed and eliminated and how these processes determine plasma concentrations of the drug. Changes in maternal physiology during pregnancy influence pharmacokinetics, and this may have important sequelae for drug dosing, especially for drugs for which adverse effects occur at concentrations within, or just above, the therapeutic range. For many drugs absorption is decreased and elimination increased, thus tending to reduce plasma concentrations. There are, however, relatively few specific data on pharmacokinetics in pregnancy, compared to the non-gravid state, because of the obvious ethical issues surrounding studies during pregnancy. Most therapeutic guidelines are thus based on observational studies and basic principles.
引用
收藏
页码:819 / 826
页数:8
相关论文